Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy

被引:75
|
作者
Bunch, T. Jared [1 ]
Munger, Thomas M. [1 ]
Friedman, Paul A. [1 ]
Asirvatham, Samuel J. [1 ]
Brady, Peter A. [1 ]
Cha, Yong-Mei [1 ]
Rea, Robert F. [1 ]
Shen, Win-Kuang [1 ]
Powell, Brian D. [1 ]
Ommen, Steve R. [1 ]
Monahan, Kristi H. [1 ]
Haroldson, Janis M. [1 ]
Packer, Douglas L. [1 ]
机构
[1] St Marys Hosp, Mayo Clin, Heart Rhythm Serv, Dept Internal Med,Div Cardiovasc Dis, Rochester, MN 55902 USA
关键词
catheter ablation; atrial fibrillation; hypertrophic cardiomyopathy; heart atrium; diastole;
D O I
10.1111/j.1540-8167.2008.01192.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Substrate and Procedural Predictors of Outcome in Patients with Hypertrophic Cardiomyopathy. Background: Hypertrophic cardiomyopathy (HCM) is often accompanied by atrial fibrillation (AF) due to diastolic dysfunction, elevated left atrial pressure, and enlargement. Although catheter ablation for drug-refractory AF is an effective treatment, the efficacy in HCM remains to be established. Methods: Thirty-three consecutive patients (25 male, age 51 +/- 11 years) with HCM underwent pulmonary vein (PV) isolation (n = 8) or wide area circumferential ablation with additional linear ablation (n = 25) for drug-refractory AF. Twelve-lead and 24-hour ambulating ECGs, echocardiograms, event monitor strips, and SF 36 quality of life (QOL) surveys were obtained before ablation and for routine follow-up. Results: Twenty-one (64%) patients had paroxysmal AF and 12 (36%) had persistent/permanent AF for 6.2 +/- 5.2 years. The average ejection fraction was 0.63 +/- 0.12. The average left atrial volume index was 70 +/- 24 mL/m(2). Over a follow-up of 1.5 +/- 1.2 years, 1-year survival with AF elimination was 62%(Confidence Interval [CI]: 66-84) and with AF control was 75%(CI: 66-84). AF control was less likely in patients with a persistent/chronic AF, larger left atrial volumes, and more advanced diastolic disease. Additional linear ablation may improve outcomes in patient with severe left atrial enlargement and more advanced diastolic dysfunction. Two patients had a periprocedureal TIA, one PV stenosis, and one died after mitral valve replacement from prosthetic valve thrombosis. QOL scores improved from baseline at 3 and 12 months. Conclusion: Outcomes after AF ablation in patients with HCM are favorable. Diastolic dysfunction, left atrial enlargement, and AF subtype influence outcomes. Future studies of rhythm management approaches in HCM patients are required to clarify the optimal clinical approach.
引用
收藏
页码:1009 / 1014
页数:6
相关论文
共 50 条
  • [41] Long-Term Outcome of Catheter Ablation for Atrial Fibrillation in Patients With Apical Hypertrophic Cardiomyopathy
    Roh, Seung-Young
    Kim, Dong-Hyeok
    Ahn, Jinhee
    Lee, Kwang No
    Lee, Dae In
    Shim, Jaemin
    Choi, Jong-Il
    Park, Sang-Weon
    Kim, Young-Hoon
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2016, 27 (07) : 788 - 795
  • [42] Long-term outcome of catheter ablation for atrial fibrillation in patients with apical hypertrophic cardiomyopathy
    Chen, Xuan
    Dong, Jian-Zeng
    Du, Xin
    Wu, Jia-Hui
    Yu, Rong-Hui
    Long, De-Yong
    Ning, Man
    Sang, Cai-Hua
    Jiang, Chen-Xi
    Bai, Rong
    Wen, Song-Nan
    Liu, Nian
    Li, Song-Nan
    Xu, Zhi-Yuan
    Ma, Chang-Sheng
    Tang, Ri-Bo
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2018, 29 (07) : 951 - 957
  • [43] Catheter Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy Long-Term Outcomes and Mechanisms of Arrhythmia Recurrence
    Santangeli, Pasquale
    Di Biase, Luigi
    Themistoclakis, Sakis
    Raviele, Antonio
    Schweikert, Robert A.
    Lakkireddy, Dhanunjaya
    Mohanty, Prasant
    Bai, Rong
    Mohanty, Sanghamitra
    Pump, Agnes
    Beheiry, Salwa
    Hongo, Richard
    Sanchez, Javier E.
    Gallinghouse, G. Joseph
    Horton, Rodney
    Dello Russo, Antonio
    Casella, Michela
    Fassini, Gaetano
    Elayi, Claude S.
    Burkhardt, J. David
    Tondo, Claudio
    Natale, Andrea
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2013, 6 (06): : 1089 - 1094
  • [44] Procedural outcomes of fluoroscopy-less catheter ablation for atrial fibrillation
    Rajkumar, S.
    Alfraih, A.
    Vivekanantham, H.
    Dadon, Z.
    Acosta, G.
    Roberts, J.
    Divakara Menon, S.
    Amit, G.
    Wong, J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [45] Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry
    Deng, Hai
    Shantsila, Alena
    Xue, Yumei
    Bai, Ying
    Guo, Pi
    Potpara, Tatjana S.
    Zhan, Xianzhang
    Fang, Xianhong
    Liao, Hongtao
    Wu, Shulin
    Lip, Gregory Y. H.
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2019, 112 (6-7) : 420 - 429
  • [46] Clinical and pathophysiologic determinants of catheter ablation outcome in hypertrophic cardiomyopathy with atrial fibrillation
    Lee, Jae-Hyuk
    Cho, Iksung
    Choi, Sung Hwa
    Yu, Hee Tae
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Joung, Boyoung
    Lee, Moon-Hyoung
    Hong, Geu-Ru
    Hwang, Chun
    Pak, Hui-Nam
    JOURNAL OF ARRHYTHMIA, 2024, 40 (03) : 479 - 488
  • [47] Renal function and outcomes in atrial fibrillation patients after catheter ablation
    Kawaji, Tetsuma
    Shizuta, Satoshi
    Aizawa, Takanori
    Yamagami, Shintaro
    Takeji, Yasuaki
    Yoshikawa, Yusuke
    Kato, Masashi
    Yokomatsu, Takafumi
    Miki, Shinji
    Ono, Koh
    Kimura, Takeshi
    PLOS ONE, 2020, 15 (11):
  • [48] Predictors and Incidence of Atrial Flutter After Catheter Ablation of Atrial Fibrillation
    Ipek, Esra Gucuk
    Marine, Joseph
    Yang, Eunice
    Habibi, Mohammadali
    Chrispin, Jonathan
    Spragg, David
    Berger, Ronald D.
    Calkins, Hugh
    Nazarian, Saman
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 (11): : 1690 - 1696
  • [49] Heartbeat: Is atrial fibrillation ablation effective in patients with hypertrophic cardiomyopathy?
    Rahimi, Kazem
    Otto, Catherine M.
    HEART, 2016, 102 (19) : 1511 - 1512
  • [50] Surgical Ablation for Atrial Fibrillation in Hypertrophic Cardiomyopathy: Outcomes of a Tailored Approach
    Hodges, Kevin
    Tang, Andrew
    Godoy, Carlos
    Desai, Milind
    Gillinov, Marc
    Smedira, Nicholas G.
    Wierup, Per
    CIRCULATION, 2019, 140